AAPL 154.28 -0.6 (-0.39%)MSFT 105.32 -0.06 (-0.06%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 154.28 -0.6 (-0.39%)MSFT 105.32 -0.06 (-0.06%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Cash Flow ABMD Quote ABIOMED Inc

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 114 38 52
Depreciation 3 3 6
DeferredIncomeT -87 22 26
StockBasedCompe 17 29 33
AccountsReceiva -8 -11 -12
InventoryCS -7 -11 -12
AccountsPayable 3 -3 8
OtherWorkingCap 2 2 2
OtherNonCashIte 2 0 -7
NetCashProvided 43 77 115
InvestmentsInPP -5 -16 -50
AcquisitionsNet -16 0 0
PurchasesOfInve -101 -262 -281
SalesMaturities 72 220 205
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI -50 -58 -126
DebtIssued 0 0 0
DebtRepayment 0 0 0
CommonStockIssu 1 1 2
CommonStockRepu -3 0 0
DividendPaid 0 0 0
OtherFinancingA 11 2 -9
NetCashProvided 10 7 4
NetChangeInCash 1 26 -9
CashAtBeginning 21 22 48
CashAtEndOfPeri 22 48 39
ABIOMED Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ABIOMED Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.